Evidence map›Paper›PMID 35113018›Full record

ArticleeLife2022

Functional visualization of NK cell-mediated killing of metastatic single tumor cells.

Hiroshi Ichise, Shoko Tsukamoto, Tsuyoshi Hirashima, Yoshinobu Konishi, Choji Oki, Shinya Tsukiji, Satoshi Iwano, Atsushi Miyawaki, Kenta Sumiyama, Kenta Terai and 1 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Natural killer cells: the immune frontline against circulating tumor cells.Journal of experimental & clinical cancer research : CR · 2025
    Review
  11. Article
  12. CD56Journal for immunotherapy of cancer · 2025
    Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Hiroshi IchiseResearch Center for Dynamic Living Systems, Graduate School of Biostudies, Kyoto University, Kyoto, Japan.ORCID 0000-0002-5187-810X
Shoko TsukamotoResearch Center for Dynamic Living Systems, Graduate School of Biostudies, Kyoto University, Kyoto, Japan.
Tsuyoshi HirashimaDepartment of Pathology and Biology of Diseases, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID 0000-0001-7323-9627
Yoshinobu KonishiResearch Center for Dynamic Living Systems, Graduate School of Biostudies, Kyoto University, Kyoto, Japan.ORCID 0000-0003-1212-7212
Choji OkiDepartment of Nanopharmaceutical Sciences, Nagoya Institute of Technology, Gokiso-cho, Nagoya, Japan.
Shinya TsukijiDepartment of Nanopharmaceutical Sciences, Nagoya Institute of Technology, Gokiso-cho, Nagoya, Japan.ORCID 0000-0002-1402-5773
Satoshi IwanoBrain Science Institute, Center for Brain Science, RIKEN, Hirosawa, Wako, Japan.
Atsushi MiyawakiBrain Science Institute, Center for Brain Science, RIKEN, Hirosawa, Wako, Japan.
Kenta SumiyamaLaboratory for Mouse Genetic Engineering, RIKEN Center for Biosystems Dynamics Research, Suita, Japan.ORCID 0000-0001-8785-5439
Kenta TeraiResearch Center for Dynamic Living Systems, Graduate School of Biostudies, Kyoto University, Kyoto, Japan.ORCID 0000-0001-7638-3720
Michiyuki MatsudaResearch Center for Dynamic Living Systems, Graduate School of Biostudies, Kyoto University, Kyoto, Japan.ORCID 0000-0002-5876-9969
Kyoto University · JPNagoya Institute of Technology · JPRIKEN Center for Brain Science · JPRIKEN Center for Biosystems Dynamics Research · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Natural killer (NK) cells lyse invading tumor cells to limit metastatic growth in the lung, but how some cancers evade this host protective mechanism to establish a growing lesion is unknown. Here, we have combined ultra-sensitive bioluminescence imaging with intravital two-photon microscopy involving genetically encoded biosensors to examine this question. NK cells eliminated disseminated tumor cells from the lung within 24 hr of arrival, but not thereafter. Intravital dynamic imaging revealed that 50% of NK-tumor cell encounters lead to tumor cell death in the first 4 hr after tumor cell arrival, but after 24 hr of arrival, nearly 100% of the interactions result in the survival of the tumor cell. During this 24-hr period, the probability of ERK activation in NK cells upon encountering the tumor cells was decreased from 68% to 8%, which correlated with the loss of the activating ligand CD155/PVR/Necl5 from the tumor cell surface. Thus, by quantitatively visualizing, the NK-tumor cell interaction at the early stage of metastasis, we have revealed the crucial parameters of NK cell immune surveillance in the lung.

Indexed as

Immunologic SurveillanceAnimalsBiosensing TechniquesCell CommunicationCell Line, TumorFemaleIntravital MicroscopyKiller Cells, NaturalLuminescent ProteinsMaleMiceMice, Inbred BALB CMice, Inbred C57BLNeoplasm MetastasisNeoplastic Cells, CirculatingLuminescent Proteinscell biologycirculating tumor cellimmunologyinflammationintravital imaginglung metastasismousenatural killer cellstumor immunology

Identifiers

PMID35113018
PMCPMC8849286
OpenAlexW4210433041

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.